Literature DB >> 2157145

Hormonal regulation of complement biosynthesis in human cell lines--II. Upregulation of the biosynthesis of complement components C3, factor B and C1 inhibitor by interleukin-6 and interleukin-1 in human hepatoma cell line.

A Falus1, H Rokita, E Walcz, M Brozik, T Hidvégi, K Merétey.   

Abstract

The effect of interleukin (IL)-6 and IL-1 on the biosynthesis of complement components C3, factor B, C2, C4 and C1 inhibitor (C1 inh), as well as that of albumin, was studied in vitro in human hepatoma-derived cell line, HepG2. Measuring the amounts of secreted complement proteins we detected a significant upregulation of C3 by both hormones. The enhancement of the factor B and especially that of C1 inh production was predominant by IL-6. In our experimental system neither IL-1 nor IL-6 affected the biosynthesis of C2 and C4. Albumin secretion was significantly decreased only in the simultaneous presence of IL-1 and IL-6. Detection of the changes in the amounts of C3- and factor B-specific mRNA of HepG2 cells suggests a pretranslational regulation by these cytokines. The secretion of C3 and factor B was markedly potentiated when IL-1 and IL-6 were added together. However only the gene expression of factor B, but not of C3, was found to reveal synergism. IL-6 enhanced the in vitro production of C3 in mouse hepatocytes as well. This effect was greatly potentiated in the presence of histamine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157145     DOI: 10.1016/0161-5890(90)90115-g

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  18 in total

1.  Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.

Authors:  O B Spiller; O Criado-García; S Rodríguez De Córdoba; B P Morgan
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  HLADR5 and C4BQO high frequency and antinuclear antibodies positivity in patients with 21 hydroxylase deficiency from Campania region.

Authors:  F Parlato; G Pisano; G Misiano; E Cosentini; C Cacciapuoti; M R Cavalcanti; M Brai; A Bellastella
Journal:  J Endocrinol Invest       Date:  1992-06       Impact factor: 4.256

3.  Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles.

Authors:  Budhaditya Mazumdar; Hangeun Kim; Keith Meyer; Sandip K Bose; Adrian M Di Bisceglie; Ratna B Ray; Michael S Diamond; John P Atkinson; Ranjit Ray
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

4.  Regulation of early complement components C3 and C4 in the synovium.

Authors:  T Collins; J A Winkelstein; K E Sullivan
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

5.  Analysis of immunoglobulin, complements and CRP levels in serum of captive northern pig-tailed macaques (Macaca leonina).

Authors:  Xiao-Liang Zhang; Wei Pang; De-Yao Deng; Long-Bao Lv; Yue Feng; Yong-Tang Zheng
Journal:  Dongwuxue Yanjiu       Date:  2014-05

6.  Histamine influences the expression of the interleukin-6 receptor on human lymphoid, monocytoid and hepatoma cell lines.

Authors:  K Merétey; A Falus; T Taga; T Kishimoto
Journal:  Agents Actions       Date:  1991-05

7.  Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity.

Authors:  C Scheid; R Young; R McDermott; L Fitzsimmons; J H Scarffe; P L Stern
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

8.  Human recombinant macrophage colony-stimulating factor (M-CSF) increases Cl-esterase inhibitor (Cl-INH) synthesis by human monocytes.

Authors:  B Schmidt; G Gyapay; M Válay; G Füst
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

9.  The acute phase protein response in patients receiving subcutaneous IL-6.

Authors:  R E Banks; M A Forbes; M Storr; J Higginson; D Thompson; J Raynes; J M Illingworth; T J Perren; P J Selby; J T Whicher
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

10.  Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema.

Authors:  J Kramer; Y Katz; F S Rosen; A E Davis; R C Strunk
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.